News & Updates
Filter by Specialty:
Extending letrozole treatment beyond 5 days induces ovulation in certain PCOS patients
For women with polycystic ovary syndrome (PCOS), if a 5-day letrozole regimen for ovulation induction does not work, extending the duration of treatment may do the job, as shown in a study.
Extending letrozole treatment beyond 5 days induces ovulation in certain PCOS patients
31 Oct 2022CHD tied to better prognosis in infective endocarditis
Among patients with infective endocarditis (IE), the presence of congenital heart disease (CHD) appears to be correlated with better short- and long-term outcomes, a new study has found.
CHD tied to better prognosis in infective endocarditis
31 Oct 2022Real-world data affirms palbociclib–AI combo efficacy in metastatic breast cancer
The use of the combination of palbociclib plus an aromatase inhibitor (AI) in the first-line treatment setting appears to confer survival advantage on patients with hormone receptor–positive/human epidermal growth factor receptor 2–negative (HR+/HER2−) metastatic breast cancer (MBC), according to real-world data.
Real-world data affirms palbociclib–AI combo efficacy in metastatic breast cancer
30 Oct 2022Low ALA levels tied to worse prognosis in HF patients
Lower levels of alpha-linolenic acid (ALA) in serum phospholipids among patients with heart failure (HF) predict a poorer prognosis relative to the highest ALA levels, a recent study has shown.